BioXcel Therapeutics BTAIQ
OTC BTAIQ
$0.05 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioXcel Therapeutics (BTAIQ) Depreciation & Amortization (CF) (2017 - 2026)

Updated

BioXcel Therapeutics' Depreciation & Amortization (CF) came in at $18,000 for Q2 2026, down 76.0% from $75,000 a year earlier and down 69.0% from the prior quarter.

Analysis

BioXcel Therapeutics (BTAIQ) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, BioXcel Therapeutics reported Depreciation & Amortization (CF) of $225,000, down 26.2% year-over-year; for FY2025, it came in at $300,000, down 2.9% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last three years, though with a five-year compound annual growth rate of 9.8% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $309,000 in FY2024 (-2.8%), $318,000 in FY2023 (-2.8%), $327,000 in FY2022 (+10.1%) and $297,000 in FY2021 (+58.0%).
  • The Q2 2026 figure represents the lowest quarterly Depreciation & Amortization (CF) since Q4 2019.
  • Year-over-year, Depreciation & Amortization (CF) has declined for 13 consecutive quarters, with an average decline of 14.4% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q4 2021 (growth of 68.9%), and the weakest in Q2 2026 (a decline of 76.0%).
  • Business Quant data shows BTAIQ's Depreciation & Amortization (CF) at $58,000 (Q1 2026), $74,000 (Q4 2025) and $75,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 1.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 194.00 Mn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.93 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 98.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 1.62 Bn
10 BioXcel Therapeutics 1.57 Mn 1.57 Mn 160,000.00 18,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 18,000.00
Mar 31, 2026 58,000.00
Dec 31, 2025 74,000.00
Sep 30, 2025 75,000.00
Jun 30, 2025 75,000.00
Mar 31, 2025 76,000.00
Dec 31, 2024 77,000.00
Sep 30, 2024 77,000.00
Jun 30, 2024 77,000.00
Mar 31, 2024 78,000.00
Dec 31, 2023 78,000.00
Sep 30, 2023 79,000.00
Jun 30, 2023 81,000.00
Mar 31, 2023 80,000.00
Dec 31, 2022 81,000.00
Sep 30, 2022 85,000.00
Jun 30, 2022 84,000.00
Mar 31, 2022 77,000.00
Dec 31, 2021 76,000.00
Sep 30, 2021 76,000.00
API Access

BioXcel Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY